Found 27 matching trials
Safety and Efficacy of BAY 50-4798 in Patients With HIV Infection PHASE1 The purpose of this study is to evaluate the safety of the experimental dru...
Show More Location
Multiple Locations
Learn More & Join Trial
The Effects of Giving Interleukin-2 (IL-2) Plus Anti-HIV Therapy to HIV-Positive Patients With CD4 Cell Counts of at Least 350 Cells/mm3 PHASE2 The purpose of this study is to evaluate the safety and tolerability of giv...
Show More Location
Thomas Street Clinic C605-020 CRS
Learn More & Join Trial
Effectiveness of Interleukin-2 (IL-2) Plus Anti-HIV Therapy in HIV-Positive Patients NA The purpose of this study is to find out if the immune systems of HIV-posit...
Show More Location
Johns Hopkins Hosp
Learn More & Join Trial
HIV Immune and Virological Responses Following the Administration of IL-2 Either Alone or Combined to ALVAC-HIV 1433 and HIV Lipopeptides in Patients Treated Early With HAART During Primary Infection PHASE2 HIV-specific immune responses are preserved in patients treated early durin...
Show More Location
Multiple Locations
Learn More & Join Trial
A Phase II Study of Low-Dose Interleukin-2 by Subcutaneous Injection in Combination With Antiretroviral Therapy Versus Antiretroviral Therapy Alone in Patients With HIV-1 Infection and at Least 3 Months Stable Antiretroviral Therapy PHASE2 PRIMARY: To examine the effect of aldesleukin ( IL-2 ) on viral activity in...
Show More Location
Alabama Therapeutics CRS
Learn More & Join Trial
A Study to Evaluate the Use of a Protease Inhibitor and of Interleukin-2 (IL-2) in the Treatment of Early HIV Infection PHASE3 The purpose of this study is to look at the effectiveness of combination an...
Show More Location
Viridae Clinical Sciences / University of British Columbia
Learn More & Join Trial
HIV Reservoir Reduction With Interleukin-2 PHASE2 The purpose of this pilot study is to examine the effects of eight 4-day cy...
Show More Location
AIDS Clinical Trials Unit
Learn More & Join Trial
Effects of Giving Interleukin-2 (IL-2) Plus Anti-HIV Therapy to HIV-Positive Patients With CD4 Cell Counts of at Least 350 Cells/mm3 PHASE2 The purpose of this study is to evaluate the safety and tolerability of giv...
Show More Location
Chulalongkorn Univ. Hosp. C603-010 CRS
Learn More & Join Trial
Safety and Effectiveness of L2-7001 (Interleukin-2) in HIV-Positive Patients Receiving Anti-HIV Therapy PHASE1 The purpose of this study is to see if it is safe and effective to give HIV...
Show More Location
Sorra Research Ctr / Med Forum
Learn More & Join Trial
Effect of Interleukin-2 on HIV Treatment Interruption NA Interleukin-2 (IL-2) helps the body make infection-fighting white blood cel...
Show More Location
UCLA CARE Center CRS
Learn More & Join Trial